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with spectrophotometry. Hence, the absorbed dose (D) is 
given by: 
D = Aλ · cλ  
where Aλ is the absorbance (λ is 395 or 603 nm) and cλ is a 
constant which depends on the radiolytic yield (i.e. the 
amount of radicals created per absorbed joule), the density, 
and the molar extinction coefficient of the solution, as well 
as the path length of the light through the solution.  
The reproducibility of the MV dose measurements was 
assessed by irradiating samples of MV solution (introduced in 
optical cuvettes) with 1000 monitor units (MU) from a clinical 
electron beam (4 MeV at an Elekta Synergy) and repeating 
this process for 20 different solutions. The linearity response 
was checked by delivering 10 – 10 000 MU to the solution, 
while the dose-rate dependence was investigated at normal 
clinical dose-rates by delivering 1 000 MU with varying dose-
rate 25 – 430 MU/min. 
Results: Our MV dose measurements show an acceptable 
level of reproducibility with a standard deviation for the 20 
measurements of 1.8 % for both wavelengths. The dosimeter 
has a linear dose-response relationship between 500 – 7 000 
MU (≈ 5 – 70 Gy), and is clinically usable (but not linear) down 
to 100 MU, see Figure 1.  
 
 
Our results show a small dose-rate dependence of the MV 
response, specifically an increase of the response with higher 
dose-rate. This behavior is most likely due to the fading of 
the signal that occurs over time and starts to become a 
considerable factor for long irradiation sessions.  
Conclusions: The results of our study show that MV is useable 
as a clinical dosimeter within radiotherapy. Although its 
characteristics cannot rival those of ion-chambers or diodes 
at normal dose-rates, its reported dose-rate independence up 
to high dose-rates makes it of clinical interest. The 
characteristics of MV can make it a vital component in taking 
promising experimental radiotherapy techniques like high 
dose rate irradiation and synchrotron radiation therapy to 
clinical trials. 
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Purpose/Objective: To present a simplified methodology for 
quantitatively assessing the effects of spatial dose delivery 
inaccuracies on DVHs and to highlight the dependence of the 
treatment outcome and patient safety on small spatial dose 
delivery errors in an hypophysis treatment case. 
Materials and Methods: The planning-CT scans, the 
RStructure dicom-RT file and the Treatment Planning System 
(TPS) calculated RDose dicom-RT file of an hypophysis patient 
treatment were imported to the open source software 3D-
slicer. Spatial dose delivery errors, ranging from 1 to 3 mm in 
all Cartesian directions, were systematically introduced to 
the TPS calculated dose dataset (RDose). To achieve this, the 
RDose dataset volume was manually moved along the x, y and 
z axes (antero-posterior, left-right and cranio-caudal 
directions respectively) while keeping spatially stationary the 
planning-CT scans and RStructure datasets. The DVHs, Dmean, 
Dmin. Dmax, V50.4 and D95% for the PTV, brainstem, right optic 
nerve and left optic nerve were calculated for the nominal 
dose delivery scenario, as well as for various simulation 
scenarios representing different spatial dose delivery errors.  
Results: For the brain tumor radiotherapy case studied 
(hypophysis), a relatively small spatial dose delivery error of 
1 mm in each axis resulted in minor DVH alterations for all 
structures. Contrarily, the worst case scenario investigated, 
i.e., 3 mm spatial dose delivery error in each axis, resulted in 
important DVH alterations for the PTV and the organs at risk. 
In the latter scenario, PTV D95% was reduced by about 18%, 
while right optic nerve D95% was increased by over 30%. 
Acquired results suggest that cranio-caudal spatial errors 
induce the more intense DVH alterations. The incorporated 
table presents the calculated values of Dmean, Dmin. Dmax, V50.4 
and D95% for all studied structures and two of the simulated 
scenarios with spatial delivery inaccuracies, whilst 
corresponding PTV DVHs are depicted in the included Figure 
(solid, dashed and dotted lines represent the scenarios of 0, 
1 and 3 mm spatial errors in each axis, respectively). 
 
S746                                                                                                                                         3rd ESTRO Forum 2015 
 
 
 
 
Conclusions: The accuracy of the spatial deposition of the 3D 
dose pattern in brain tumor radiotherapy is strongly 
correlated to treatment outcome and patient safety. In the 
hypophysis treatment simulated, the combined effect of 3 
mm spatial inaccuracy in each direction can significantly 
alter the DVHs of the target and the organs at risk. The 
proposed methodology, which employs the planning-CT scans, 
the RStructure and RDose dicom-RT files as well as the open 
source software 3D-slicer, can be used for quantifying the 
effect of spatial errors on dose delivery accuracy in any 
selected treatment site and/or treatment plan. This 
simplified approach could be used in the appraisal of the 
quality and robustness of a specific clinical treatment plan or 
for plan intercomparison with regard to the relative 
sensitivity of dosimetric outcome to spatial uncertainties.  
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Purpose/Objective: Diamond detectors are used in 
fundamental nuclear physics and many others fields of 
applied science. Its radiation hardness and electrical 
properties make them ideal to work under extreme 
conditions. The main goal of this work is to study the 
advantages of using diamond detectors as neutron dosimeter 
for both protontherapy and conventional radiotherapy 
accelerators.  
Materials and Methods: 
a) Neutron from a 252Cf source: 
The diamond detector was mounted inside a reaction 
chamber close to a 252Cf source. A shielding of 3.2 mm of lead 
was placed between detector and source to avoid heavy 
products deposition.  
b) Neutrons from a conventional radiotherapy accelerator: 
Measurements were performed using the 15 MV photons mode 
at the Juan Ramón Jímenez Hospital radiotherapy 
accelerator. In order to minimize the photon radiation all 
collimators were closed and diamond detector was shielded 
with lead.  
c) Neutron produced in a reaction scenario at a 3 MV 
Tandem: 
The experiment took place at the Centro Nacional de 
Aceleradores (CNA) in Sevilla. Neutrons produced by a 
12C(2H,n)13N reaction were detected outside the reaction 
chamber by our diamond detector placed 0º off the beam 
axis by the target position. 
Results: After 40 days non-stop measurement with the 252Cf 
source, the expected elastic collision ramp due to elastically 
scattered neutrons was observed an activation peak was 
observed too. Similarly, our single crystal diamond detector 
placed alongside the radiotherapy accelerator showed the 
expected shape too. At the CNA Tandem, the analogous 
shape was obtained at the forward diamond detector. Several 
peaks due to charged particles at the 90º diamond detector 
were observed in a monitor system in vacuum. Good 
agreement between experimental data and simulations has 
been achieved. 
Conclusions: Our experimental setup is ready to detect 
neutrons coming from different sources. Diamond detector is 
showing a promising behavior in neutron detection devoted 
to measurement at medical facilities. Simulations generated 
with GAMOS-GEANT4 show a good agreement with 
experimental data. 
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Purpose/Objective: Stereotactic body radiation therapy 
(SBRT) is a type of radiation therapy in which the dose is 
delivered to small, well-defined tumors using a high dose per 
fraction scheme. Our centre uses the ArcCHECK phantom 
manufactured by Sun Nuclear (SNC Melbourne, FL) to perform 
the pre-treatment verification of IMRT and VMAT plans. The 
ArcCHECK features a High Density (HD) measurement 
procedure in which the measurement resolution is doubled. 
The purpose of the present work is to evaluate whether this 
HD mode is required for pre-treatment QA of our SBRT plans. 
Materials and Methods: Ten different SBRT (VMAT) plans 
were calculated with Varian Eclipse treatment planning 
system (TPS) using the analytical anisotropic algorithm (AAA 
version 10.0.28). The plans were made for a TrueBeam linear 
accelerator (Varian Medical Systems, Palo Alto, CA), with 6 
MV arcs using either a Flattening Filter (FF) or a Flattening 
Filter-Free (FFF) configuration. The degree of modulation 
